Abstract
Liposomal drug delivery systems (LDDS) have revolutionized pharmaceutical therapy by enhancing the therapeutic index of drugs through improved pharmacokinetics and targeted delivery. These nanocarriers offer a biocompatible, versatile platform to encapsulate a wide range of bioactive compounds, reducing toxicity and improving bioavailability. Advances in liposomal formulation, including PEGylation, ligand targeting, and stimuli-responsive systems, have further expanded their clinical utility. This review provides a comprehensive overview of modern liposomal technologies and their implications in drug delivery.
References
Ahmad, N. R. (2025). Financial inclusion: How digital banking is bridging the gap for emerging markets.
Ahmad, N. R. (2025). Exploring the relationship between leadership styles and employee motivation in remote work environments.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 American Journal Of Pharmacy And Pharmacology